http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0180833-B1

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-08
filingDate 1985-10-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1989-07-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1989-07-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-0180833-B1
titleOfInvention 4-Oxo-pyrido-[2,3-d]pyrimidine derivatives, process for their preparation and medicaments containing them
abstract 4-Oxo-pyrido[2,3-d]pyrimidine derivatives are herein described as well as processes for their preparation. These compounds possess valuable pharmacological properties. As calcium antagonists they exert vasospasmolytic, vasodilatory, and antihypertensive activities. Surprisingly some of the compounds also have the effect of increasing contractility. They are therefore particularly suited for the treatment of vascular diseases.
priorityDate 1984-10-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6251
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID235812420
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID136456170
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID232350877
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID136456151
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7914
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID136460
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID232350391
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393819
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID235810605
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID69852037
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394073
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID235810526
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID235811329
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID235810940
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID70388149
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID444020
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID69852253
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226670780
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID468356911
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226397450
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226413434
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID136456158
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135440277
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID70388042

Total number of triples: 46.